Ae Wealth Management LLC Intercept Pharmaceuticals, Inc. Transaction History

Ae Wealth Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 Apr 27, 2021	SELL	$19.33 - $37.75 $373,610 - $729,632	-19,328 Closed	0 $0
Q4 2020 Feb 01, 2021	BUY	$24.48 - $42.47 $115,031 - $199,566	4,699 Added 32.12%	19,328 $477,000
Q3 2020 Nov 06, 2020	BUY	$39.09 - $53.44 $80,408 - $109,926	2,057 Added 16.36%	14,629 $607,000
Q2 2020 Aug 05, 2020	BUY	$46.7 - $92.04 $587,112 - $1.16 Million	12,572 New	12,572 $602,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Ae Wealth Management LLC, based on Form 13F filings with the SEC.

Stay updated on Ae Wealth Management LLC with notifications on news.